Dr. Stanley Fineman, president of the American College of Allergy, Asthma and Immunology, (ACAAI) is available to comment on the School Access to Emergency Epinephrine Act, a federal bill introduced today that will help make epinephrine available in schools for the immediate treatment of anaphylactic reactions to food or other allergens.
Dr. Fineman can discuss the importance of immediate access to epinephrine, the first-line treatment for an allergic emergency or anaphylactic reaction. Delay in treating these reactions can have severe consequences including death. Recent deaths of teens in Georgia and Illinois, who did not have immediate access to epinephrine, underscore the importance of immediate treatment and the passage of this legislation.
New study confirms: Anti-inflammatory inhalers reduce severe asthma complications